Ali I, Schuh L, Barkley G, Gates J. Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav. 2004;5:296–300.
Article
PubMed
Google Scholar
Arora S, Bubb C, Karam J, McFarlane S. Expanding use of anti-epileptic therapy: implications on bone disease. Summ Ther. 2007;4(1):79–89.
CAS
Google Scholar
Beerhorst K, Huvers FC, Renier WO. Severe early onset osteopenia and osteoporosis caused by antiepileptic drugs. Neth J Med. 2005;63(6):222–6.
CAS
PubMed
Google Scholar
Boluk A, Guzelipek M, Savli H, Temel I, Ozisik H, Kaygusuz A. The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res. 2004;50:93–7.
Article
CAS
PubMed
Google Scholar
Canevini M, De Sarro G, Galimberti C. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 1995;51:797–804.
Article
Google Scholar
Dennis L, Judy O, David T, Lucinda G, Meshell J, Arnold F, William S. Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol. 2005;59(5):781–6.
Google Scholar
Ecevit C, Aydogan A, Kavakli T, Altinoz S. Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol. 2004;31:279–82.
Article
PubMed
Google Scholar
Erbayat Altay E, Serdaroglu A, Tumer L, Gucuyener K, Hasanoglu A. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab. 2000;13:933–9.
Article
CAS
PubMed
Google Scholar
Espallargues M, Sampietro-Colom L, Estrada M, Sola M, del Rio L, Setoain J, Granados A. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int. 2001;12:811–22.
Article
CAS
PubMed
Google Scholar
Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj FG. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology. 2002;58:1348–53.
Article
CAS
PubMed
Google Scholar
Feldkamp J, Becker A, Witte O, Scharff D, Scherbaum W. Long term anticonvulsant therapy leads to low bone mineral density—evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrinol Diabetes. 2000;108:37–43.
CAS
PubMed
Google Scholar
Genant H, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin B, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi Eis S, Gennari C, Johnell O, Johnston C, Lau E, Liberman U, Lindsay R, Martin T, Masri B, Mautalen C, Meunier P, Khaltaev N. Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int. 1999;10:259–64.
Article
CAS
PubMed
Google Scholar
Hamed S, Moussa E, Youssef A, El Hameed M, Nasr el din E. Bone status in patients with epilepsy; relationship to markers of bone remodeling. Front Neurol. 2014;5(142):1–7.
Google Scholar
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:7.
Google Scholar
Kafali G, Erselcan T, Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr. 1999;38:93–8.
Article
CAS
Google Scholar
Kishk N, Aboumousa A, Abdallah F, Talaat S. Assessment of bone mineral density by DEXA scan in seventy five epileptic patients. Med J Cairo Univ. 2008;2(11):337–43.
Google Scholar
Mattson R, Gidal B. Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav. 2001;52:36–40.
Google Scholar
Mikati M, Dib L, Yamout B, Sawaya R, Rahi A, El-Hajj FG. Two randomized vitamin D trials in ambulatory patients on anticonvulsants and their impact on bone neurology. Neurology. 2006;67:11.
Article
Google Scholar
Mintzer S. Metabolic consequences of antiepileptic drugs. Curr Opin Neurol. 2010;23:s164–9.
Article
Google Scholar
Oner N, Kaya M, Karasalihoglu S, Karaca H, Celtik C, Tutunculer F. Bone mineral metabolism changes in epileptic children receiving valproic acid. J Paediatr Child Health. 2004;40:470–3.
Article
CAS
PubMed
Google Scholar
Pack A, Gidal B, Vazquez B. Bone disease associated with antiepileptic drugs. Cleve Clin J Med. 2004;71(2):42–8.
Article
Google Scholar
Pack M, Morrell J. Epilepsy and bone health in adults. Epilepsy Behav. 2004;5(2):24–9.
Article
Google Scholar
Pascussi J, Robert A, Nguyen M, Walrant-Debray O, Garabedian M, Martin P, Pineau T, Saric J, Navarro F, Maurel P, Vilarem M. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest. 2005;115:177–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Petty S, Paton L, O'Brien T, Makovey B, Erbas P, Sambrook S, Berkovic J, Wark D. Effect of antiepileptic medication on bone mineral measures. Neurology. 2005:65–9.
Shaker E, Talaat S, Rashed L. Risk factors for bone loss in epileptic patients. Egypt J Neurosurg. 2009;46(2):589–95.
Google Scholar
Sheth R, Binkley N, Hermann B. Progressive bone deficit in epilepsy. Neurology. 2008;70:170–6.
Article
PubMed
Google Scholar
Sheth R, Wesolowski C, Jacob J, Penney S, Hobbs G, Riggs J, Bodensteiner J. Effect of carbamazepine and valproate on bone mineral density. J Pediatr. 1995;127:256–62.
Article
CAS
PubMed
Google Scholar
Souverein P, Webb D, Petri H, Weil J, VanStaa T, Egberts T. Incidence of fractures among epilepsy patients: a population based retrospective cohort study in the general practice research database. Epilepsia. 2005;46:304–10.
Article
PubMed
Google Scholar
Stephen L, Brodie M. Antiepileptic drug monotherapy versus polytherapy: pursuing seizure freedom and tolerability in adults. Curr Opin Neurol. 2012;25(2):164–72.
Article
CAS
PubMed
Google Scholar
Stephen L, McLellan A, Harrison J, Shapiro D, Dominiczak M, Sills G, Brodie M. Bone density and antiepileptic drugs: a case controlled study. Seizure. 1999;8:339–42.
Article
CAS
PubMed
Google Scholar
Sweileh W, Ihbesheh M, Jarar I, Taha A, Sawalha A, Zyoud S, Jamous R, Morisky D. Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav. 2011;21:301–5.
Article
PubMed
Google Scholar
Valimaki M, Tiihonen M, Laitinen K, Tahtela R, Karkkainen M, Lamberg-Allardt C, Makela P, Tunninen R. Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res. 1994;9:631–7.
Article
CAS
PubMed
Google Scholar
Valsamis H, Surender K, Barbara L, SI MF. Antiepileptic drugs and bone metabolism. Nutr Metab. 2006;3:36.
Article
Google Scholar
Van der Sluis M, de Ridder M, Boot A, Krenning E. Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Arch Dis Child. 2002;87:341–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Verrotti A, Giangennaro C, Pasquale P, Angelika M, Francesco C. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010;112(1):1–10.
Article
PubMed
Google Scholar
Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. Increased bone turnover in prepsubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia. 2002;43:1488–92.
Article
CAS
PubMed
Google Scholar
Verrotti A, Greco R, Morgese G, Chiarelli F. Increased bone turnover in epileptic patients treated with carbamazepine. AnnNeurol. 2000;47:385–8.
CAS
Google Scholar
Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004;45:1330–7.
Article
CAS
PubMed
Google Scholar
Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L. Fracture risk is increased in epilepsy. Acta Neurol Scand. 1999;99:269–75.
Article
CAS
PubMed
Google Scholar